What are the symptoms of polycythemia vera?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Polycythemia Vera

Polycythemia vera presents with a characteristic constellation of symptoms including microvascular disturbances (headache, light-headedness, transient neurologic or ocular disturbances, tinnitus, atypical chest discomfort, paresthesias), pruritus (affecting up to 48% of patients), and erythromelalgia (painful burning sensations of the hands and feet), along with increased risk of thrombotic and hemorrhagic complications. 1, 2

Microvascular Disturbances

These symptoms result from platelet-mediated endothelial injury and transient thrombotic occlusion of arterioles: 1

  • Headache and light-headedness are common presenting complaints 2
  • Transient neurologic or ocular disturbances occur frequently, with neurologic complications affecting 50-80% of patients 3
  • Tinnitus (ringing in the ears) 1, 2
  • Atypical chest discomfort that may mimic cardiac disease 1, 2
  • Paresthesias (abnormal sensations) 1, 2
  • Dizziness related to hyperviscosity 3

Erythromelalgia

Erythromelalgia is a distinctive and characteristic feature of polycythemia vera, occurring in approximately 3-5.3% of patients: 1, 4, 2

  • Presents as painful and burning sensations of the feet or hands 1, 2
  • Associated with erythema (redness) and warmth of affected areas 1, 2
  • Results from platelet-mediated arteriolar inflammation and increased thromboxane production 4
  • Responds promptly (within hours) to low-dose aspirin (81 mg/day) in most cases 1, 2

Pruritus (Itching)

Generalized pruritus is one of the most characteristic and agonizing symptoms of polycythemia vera: 1

  • Documented in up to 48% of patients either at diagnosis or later in disease course 1, 2
  • Characteristically exacerbated by hot baths or showers (aquagenic pruritus), affecting approximately one-third of patients 1, 4
  • May be the most debilitating aspect of the disease 1
  • Can result in sleep deprivation and interference with social and physical activities 1
  • May correlate with iron deficiency (low mean corpuscular volume) 1

Constitutional Symptoms

  • Fatigue is a substantial component of symptom burden 5, 6
  • Bone pain may occur 6
  • Splenomegaly (enlarged spleen) develops in many patients 7

Thrombotic Complications

Patients are at high risk for both arterial and venous thrombotic events: 5, 6, 3

  • Stroke 6
  • Myocardial infarction 6
  • Pulmonary embolism 6
  • Deep vein thrombosis 6
  • Splanchnic vein thrombosis 7
  • Twenty-year risk for thrombosis is approximately 26% 7

Hemorrhagic Manifestations

Bleeding complications can occur, particularly in specific circumstances: 4, 3

  • Most common in patients with extreme thrombocytosis (platelet count ≥1000 × 10⁹/L) 4
  • Results from acquired von Willebrand disease due to decreased large von Willebrand factor multimers abnormally adsorbed to clonal platelets 4
  • Patients are paradoxically prone to hemorrhages despite thrombotic risk 3

Clinical Phenotype

  • Plethora (ruddy, reddish complexion) 1
  • Engorged veins visible on examination 1
  • Associated with leukocytosis and thrombocytosis in addition to erythrocytosis 1

Important Clinical Pitfall

The symptoms related to hyperviscosity (headache, dizziness) respond immediately to reduction of cell counts through phlebotomy, while microvascular symptoms like erythromelalgia respond specifically to aspirin therapy. 1, 3 Failure to distinguish between these symptom categories may lead to inadequate symptom management even when hematocrit is controlled.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Polycythemia Vera Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Polycythemia Vera Clinical Manifestations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Polycythemia Vera: Thinking Beyond the Hematocrit.

Journal of the advanced practitioner in oncology, 2023

Related Questions

Can polycythemia vera (a myeloproliferative disorder) cause brown vascular lesions on the hands?
What is the appropriate management for a patient with elevated hematocrit, high MCV, and low MCHC levels on their CBC results?
What blood tests are used to monitor Polycythemia vera?
What is the management approach for a middle-aged male patient with blurring vision, polycythemia, and normal visual acuity (VA)?
What is the treatment for excess red blood cells?
Is testosterone replacement therapy necessary for an adult male with a history of hyperprolactinemia, well-controlled on cabergoline (dopamine agonist), who has low free testosterone and high Sex Hormone-Binding Globulin (SHBG) despite normal total testosterone levels?
What is the management plan for a patient with vitamin D deficiency presenting with bone deformity?
What is turf toe, a condition affecting the big toe in athletes who participate in sports involving running, jumping, or quick changes of direction?
What antibiotics can be used to de-escalate from piperacillin-tazobactam (Pip/Taz) in a patient with a history of penicillin allergy and impaired renal function?
How do we initiate, titrate, and discontinue premixed insulin (e.g. 70/30 or 50/50 insulin mixture) in patients with impaired glucose regulation, considering factors such as medical history, including impaired renal (kidney) function or hepatic (liver) disease?
What is the next step in evaluating a patient with an elevated D-dimer (D-dimer test) level of 995, presenting with symptoms such as leg swelling, chest pain, or shortness of breath, and potentially at risk for Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.